CPhI North America takes place from April 30 to May 2, 2019 in Chicago, IL, USA. It has become the link in a global chain connecting motivated buyers with industry-leading suppliers. Join us at the conference where you can find the full pharma supply chain under one roof!
We invite you to visit us at our Booth #2349: please contact us to schedule a meeting in advance.
We look forward to meeting you at CPhI North America 2019!
Endogenous opioid peptides and their receptors play a role in a variety of functions including pain relief, modulation of mood and stress responses, and control of food intake. In addition, they are implicated in different aspects of addiction.
Opioid receptors serve as important drug targets and opioid peptide analogs are of interest for the treatment of pain and other conditions such as mood disorders and substance abuse. For example, peptide-based analgesics are being explored in the search for safer alternatives to existing opioid drugs because they may produce less tolerance, respiratory suppression, and addiction.
This month's highlights include news about a fungal antimicrobial peptide that is active against Mycobacterium tuberculosis, a nonsurgical approach to address peri-implant disease using a bifunctional peptide film, a promising novel peptide-based immunotherapy for peanut allergy, and a novel nanomedicine approach, allowing the specific delivery of Leu-enkephalin (LENK) neuropeptide into inflamed tissues for pain control.
Marketing Dr. Martina Diekmann Vice President Global Marketing
cell +41 79 945 9107 Marketing Stefan Andlauer, EMBA Director Science & Relationship Marketing
phone +41 58 595 2107
CHAT WITH US!
MEET BACHEM AT UPCOMING EXHIBITS AND EVENTS
CPhI North America Chicago, IL, USA April 30 - May 2, 2019 21st GFPP Meeting Amboise, France May 12-16, 2019 BIOMED Israel Tel Aviv, Israel May 14-16, 2019 TIDES San Diego, CA, USA May 20-23, 2019 Make an appointment and meet us in person. Contact
|sasas
Contact Us
Americas: Bachem Americas, Inc. Toll Free (USA and Canada): +1 888 422 2436 or Tel: +1 310 539 4171
